首页> 外国专利> Autologous and allogenic adipose-derived stromal stem cell composition for treating fistulas

Autologous and allogenic adipose-derived stromal stem cell composition for treating fistulas

机译:自体和同种异体脂肪来源的基质干细胞组合物治疗瘘

摘要

The present invention relates to a method for producing clinically effective quantities of human adipose tissue-derived stromal cells for treating fistulas and a composition made with the same. The method of the present invention can efficiently produce clinically effective number of adipose tissue-derived stromal cells within a short period by improving conventional standard culturing methods. The adipose stem cells composition containing the adipose tissue-derived stromal cells obtained by the method of the present invention exhibit superior multipotency and immunomodulatory activity over those of a cell composition produced by conventional methods, and thus is more suitable for treating fistulas. The cell composition of the present invention has excellent clinical usages especially since immune response is suppressed in allogenic adipose-derived stem cells.
机译:本发明涉及产生临床有效量的人脂肪组织来源的基质细胞用于治疗瘘的方法和用其制备的组合物。通过改进常规的标准培养方法,本发明的方法可以在短时间内有效地产生临床有效数量的脂肪组织来源的基质细胞。通过本发明的方法得到的含有脂肪组织来源的基质细胞的脂肪干细胞组合物,与通过常规方法制造的细胞组合物相比,显示出优异的多能性和免疫调节活性,因此更适合于治疗瘘管。本发明的细胞组合物具有优异的临床用途,特别是因为异体脂肪来源的干细胞的免疫应答被抑制。

著录项

  • 公开/公告号IL215491A

    专利类型

  • 公开/公告日2015-06-30

    原文格式PDF

  • 申请/专利权人 ANTEROGEN CO. LTD.;

    申请/专利号IL20110215491

  • 发明设计人

    申请日2011-10-02

  • 分类号A61K;A61P;C12N;

  • 国家 IL

  • 入库时间 2022-08-21 15:15:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号